Beranda › Kanker Saluran Empedu (Kolangiokarsinoma) › Texas › Houston
Uji klinis Kanker Saluran Empedu (Kolangiokarsinoma) di Houston, TX
13 studi untuk Kanker Saluran Empedu (Kolangiokarsinoma) mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of PHST001 in Advanced Solid Tumors
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- University of Texas MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Menerima pesertaFase 1
- Baylor College of Medicine, Houston
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Menerima pesertaFase 1/2
- Next Oncology - Houston, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Menerima pesertaFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Menerima pesertaFase 2
- University of Texas MD Anderson Cancer Center, Houston
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Menerima pesertaFase 1/2
- University of Texas, MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Menerima pesertaFase 1/2
- MD Anderson Cancer Center, Houston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Menerima pesertaFase 1
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
Menerima pesertaStudi observasional
- M D Anderson Cancer Center, Houston
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Menerima pesertaFase 2
- M D Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Houston
Uji klinis Kanker Saluran Empedu (Kolangiokarsinoma) di kota lain
- New York City, NY11 studi
- Boston, MA8 studi
- Rochester, MN7 studi
- Arlington, VA7 studi
- Los Angeles, CA7 studi
- Chicago, IL7 studi
- Columbus, OH6 studi
- Cleveland, OH6 studi
- Queens, NY5 studi
- Edison, NJ5 studi
- Grand Rapids, MI5 studi
- Nashville, TN5 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.